ATF3 and metastatic malignant neoplasm in the lymph nodes: Additionally, ATF3 expression was negatively associated with the clinical stage (P = 0.041, Figure 1B), lymph node metastasis (P = P-0.039, Figure 1C), poor OS (P = 0.056), and DFS (P = 0.021) (Figures 1D,E).